Latest News About Novo Nordisk A/S - Site Bagsværd (Nn1)

Updated 2026-05-06 12:05

I don’t have live access to current news feeds in this moment. Here’s a concise plan to get you the latest on Novo Nordisk A/S, Bagsværd (NN1):

Would you like me to fetch and summarize the latest items now, and provide citations after each claim? If you have a preferred news source (e.g., Novo Nordisk newsroom, Reuters, Bloomberg), tell me and I’ll prioritize it.

Sources

Novo Nordisk A/S | Globenewswire

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

via.ritzau.dk

Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.

www.novonordisk.com

Novo Nordisk A/S

Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark. News … Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production...

chemanager-online.com

Newsroom | Novo Nordisk

Here journalists can access a concise and up-to-date overview of our company’s key facts, figures, and milestones.

www.novonordisk.com

Novo Nordisk A/S | Globenewswire - Via Ritzau

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

via.ritzau.dk